Begin main content

Reports

We found 4974 result(s)

Emerging Drug List — Metastatic Melanoma Vaccines

Published on: February 3, 2006
Result type: Reports
Product Line: Emerging Drug List

Tags

Cancer Vaccines, Neoplasm Vaccines, Tumor Vaccines, Vaccines, Cancer, Vaccination, Melanoma, Melanoameloblastoma, Vaccines, Tumor, Vaccines, Neoplasm, Vaccines, Cancer, Vaccines, Cancer, Vaccin Anticancéreux, neoplasm, tumor, inoculation, inoculations, vaccinations, vaccine, Allovectin-7, M-Vax, Oncophage, Mélanome, metastatic melanoma, recurrent metastatic melanoma, melanoma vaccines

Emerging Drug List — Vaccines for HIV

Published on: February 1, 2006
Result type: Reports
Product Line: Emerging Drug List

Tags

AIDS Vaccines, HIV Vaccines, Vaccination, Vaccines, Acquired Immunodeficiency Syndrome, AIDS, HIV, Vaccines, HIV/AIDS, Vaccin anti-SIDA, AIDS vaccine, HIV vaccine, inoculation, inoculations, vaccinations, vaccine, AIDSVAX, ALVAC, ALVAC-HIV vCP1521, ALVAC-HIV, SIDA

Emerging Drug List — Vaccine for Herpes Zoster

Published on: January 27, 2006
Result type: Reports
Product Line: Emerging Drug List

Tags

Vaccines, Vaccination, Chickenpox, Herpes Zoster, Zona, Shingles, Zostavax, Injections, Varicella-Zoster Virus, Postherpetic Neuralgia, Vaccines, Vaccination, vaccine, Varicelle, herpes-zoster

Pegvisomant (Somavert)

Last Updated: January 25, 2006
Result type: Reports
Product Line: Common Drug Review
Generic Name: Pegvisomant
Indications: acromegaly

  • Brand Name: Somavert
  • Manufacturer: Pfizer Canada Inc.
  • Project Number: S0050
  • Project Status: Complete
  • Submission Type: New

Transdermal Hormone Replacement Therapy Patches for Women with Postmenopausal Symptoms: Economic Analysis of Short-Term Use

Published on: January 25, 2006
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology Transdermal hormone replacement therapy (HRT) patches allow estradiol to be absorbed through the skin and released into the blood stream in metered doses. The patch needs to be changed once or twice a week. The most commonly used HRT patches in Canada are Climara ®, Vivelle ® and Estraderm MX50. Issue Postmenopausal symptoms can be tr...

Tags

Hormone Replacement Therapy, Hormones, Estrogen Replacement Therapy, Menopause, Administration, Costs and Cost Analysis, Cost Analysis, Cost-Benefit Analysis, Dermatology, Administration, Cutaneous, Postmenopause, Transdermal Patch, Dermatology, Traitement hormonal substitutif, HRT, Hormone Therapy, ERT, Estrogen Therapy Menopause, Postmenopausal, Hot flash, Cutaneous, Voie cutanée, Transdermal, Hormone Patch, Hormone Patches Economics, Économie, Economic analysis, Coût et analyse Coût, Costs, Analyse coût bénéfice

Non-physicians Performing Screening Flexible Sigmoidoscopy: Clinical Efficacy and Cost-effectiveness

Published on: January 24, 2006
Result type: Reports
Product Line: Health Technology Assessment, Technology Reports

Technology Flexible sigmoidoscopy (FS) performed by non-physicians for colorectal cancer screening (CRC). Disease In Canada , CRC is the fourth most common cancer in terms of incidence, and the second leading cause of cancer-related death. Individuals with a family history of cancer, and those with chronic inflammatory bowel disease are at a hig...

Tags

Endoscopy, Sigmoidoscopy, Sigmoidoscopes, Cost Analysis, Colorectal Cancer, Screening, Colorectal cancer, Endoscopie, Nurse endoscopy, Nonphysician endoscopy, Non-physician endoscopy, Nurse sigmoidoscopy, Nonphysician sigmoidoscopy, Non-physician sigmoidoscopy, Colonoscopy Coloscopie, Colonoscopes Coloscope, Nurses Role rôle infirmière, Nurse Practitioners infirmières praticiennes, Health practitioners, Economics Économie, Economic analysis, Costs and Cost Analysis Coût et analyse Coût, Costs

Health Technology Update — Issue 2

Published on: January 24, 2006
Result type: Reports
Product Line: Health Technology Update

Health Technology Update covers a cross section of new or innovative health technologies that may or may not have Health Canada approval. Some of the technologies may already be licensed for use in the US or elsewhere, while others are being used only in clinical trials. Some not-so-new technologies are already licensed for use in Canada, but hi...

Intragastric Balloons: A Temporary Treatment for Obesity

Published on: January 16, 2006
Result type: Reports

Summary Intragastric balloons are a temporary non-surgical obesity treatment that induces short-term weight loss by partially filling the stomach to achieve satiety and reduce food intake. Moderate weight loss may be achieved if patients adhere to a weight-reduction program. Weight gain often recurs when the balloon is removed after six months. ...

Tags

Gastric Balloon, Obesity, Weight Loss, Weight Reduction, Diet, Medical devices, Diet, Ballon Gastrique, BIB BioEnterics Intragastric Balloon System, Heliosphere, Heliosphere Intragastric Balloon System, intragastric balloon, intragastric balloons, intra gastric balloon, intra gastric balloons, Obésité, obese, Perte Poids, weight reducing, weight decrease, weight control, Ballon Intra-gastrique BioEnterics®, HéliosphèreLe ballon intra-gastrique Héliosphère, ballon intra-gastrique, ballons intra-gastriques, obèse, réducteur de poids, réduction de poids, diminution de poids, contrôle du poids

Emerging Drug List — Vaccines for Metastatic Hormone-refractory Prostate Cancer

Published on: December 22, 2005
Result type: Reports
Product Line: Emerging Drug List

Tags

Cancer Vaccines, Neoplasm Vaccines, Tumor Vaccines, Vaccines, Cancer, Immunotherapy, Active Immunotherapy, Prostatic Neoplasms, Cancer of Prostate, Prostate Cancer, Cancer of the Prostate, Neoplasms, Prostate, Prostate Neoplasms, Prostatic Cancer, Neoplasms, Prostate, Neoplasms, Prostatic, Immunotherapy, Active, Vaccines, Tumor, Vaccines, Neoplasm, Vaccines, Cancer, Vaccines, Cancer, Prostate cancer, Vaccin Anticancéreux, neoplasm, tumor, vaccine, Active, Immunothérapie Active, Tumeur prostate, prostatic, HRPC, Provenge, GVAX